β2-Adrenergic receptor antagonists protect against ventricular fibrillation: In vivo and in vitro evidence for enhanced sensitivity to β2- adrenergic stimulation in animals susceptible to sudden death

Circulation

Volumn 96, Issue 6, 1997, Pages 1914-1922

  Billman, George E ^a   Castillo, Lourdes C ^a   Hensley, James ^a   Hohl, Charlene M ^a   Altschuld, Ruth A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cells; Death, sudden; Myocardial ischemia; Receptors, adrenergic, beta

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; ISOPRENALINE; ZINTEROL; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CYCLIC AMP; ETHANOLAMINE DERIVATIVE; IMIDAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DOG; DOSE RESPONSE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; EXERCISE TEST; HEART MUSCLE; METABOLISM; MORTALITY; MUSCLE CELL; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM; CELLS, CULTURED; CYCLIC AMP; DEATH, SUDDEN; DOGS; ETHANOLAMINES; EXERCISE TEST; IMIDAZOLES; ISOPROTERENOL; MUSCLE FIBERS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-2; SENSITIVITY AND SPECIFICITY; VENTRICULAR FIBRILLATION;

EID: 0030610120     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1914     Document Type: Article

References (41)

1. Corr PB, Yamada K, Witkowski FX. Mechanisms controlling cardiac autonomic function and their relationships to arrhythmo-genesis. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations. New York, NY: Raven Press; 1986:1343-1404.
2. Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction: an experimental preparation for sudden cardiac death. Circulation. 1984;69:790-800.
3. Held P, Yusuf S. Early intravenous beta-blockade in acute myocardial infarction. Cardiology. 1989;76:132-143.
4. 2+ channel blockers in acute myocardial infarction. Eur Heart J. 1993;14(suppl F):18-25.
5. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 1991;43:203-242.
6. 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
7. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
8. 2-adrenergic stimulation. Circulation. 1995;92:1612-1618.
9. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250-258.
10. 2+ channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation. J Pharmacol Exp Ther. 1989;248:1334-1342.
11. 2+ channel antagonist, mibefradil, on refractory period and arrhythmias induced by programmed electrical stimulation and myocardial ischemia: a comparison with diltiazem and verapamil. J Pharmacol Exp Ther. 1996;277:1517-1526.
12. Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 1983;5:430-437.
13. Sonnenblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new synthetic cardioactive sympathetic amine. N Engl J Med. 1979;300:17-22.
14. 2+ transients. Circ Res. 1991;69:1369-1379.
15. Davis MH, Altschuld RA, Jung DW, Brierley GP. Estimation of intramitochondrial pCa and pH by fura-2 and 2,7 biscarboxyethyl-5(6)-carboxyfluorescein (BCECF) fluorescence. Biochem Biophys Res Commun. 1987;149:40-45.
16. Legato MJ. The anatomic matrix as a factor in susceptibility to lethal arrhythmias in a canine model of sudden cardiac death. J Mol Cell Cardiol. 1993;25:501-508.
17. Deegan R, He HB, Krivoruk Y, Wood AJ, Wood M. Regulation of norepinephrine release by beta 2-adrenergic receptors during halothane anesthesia. Anesthesiology. 1995;82:1417-1425.
18. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
19. DeFerrari GM, Salvati P, Grossoni M, Ukmar G, Vaga L, Patrono C, Schwartz PJ. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death: a study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. J Am Coll Cardiol. 1993;22:283-290.
20. Ryden L, Ariniego R, Amman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedgard P, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C. Wedel H, Yamamoto M. A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachyarrhythmias. N Engl J Med. 1983;308:614-618.
21. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J. 1985;6:199-226.
22. Salathia KS, Barber JM, McIlmoyle EL, Nicholas J, Evans AE, Elwood JH, Cran G, Shanks RG, Boyle DM. Very early intervention with metoprolol in suspected acute myocardial infarction. Eur Heart J. 1985;6:190-198.
23. Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Ryden L, Swedbera K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981;2:823-827.
24. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet. 1988;1:921-923.
25. Norris RM, Barnaby PF, Brown MA, Geary GG, Clarke ED, Logan RL, Sharpe DN. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984;2:883-886.
26. A randomized trial of propranolol in patients with acute myocardial infarction. I: mortality results. JAMA. 1982;247:1707-1714.
27. 1-selective and nonselective β-adrenergic receptor blockade and cardiac sympathetic activity in congestive heart failure. Circulation. 1996;94:353-358.
28. Robin ED, Lewiston N. Unexpected, unexplained sudden death in young asthmatic subjects. Chest. 1989;96:790-793.
29. Robin ED, McCauley R. Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. Chest. 1992;101:1699-1702.
30. 2+ in cardiac Purkinje fibers. Biophys J. 1982;38:259-269.
31. 2+ antagonists. J Cardiovasc Pharmacol. 1991;18:S107-S117.
32. 2+ in arrhythmogenesis. Circulation. 1989; 80(suppl IV):IV-23-IV-30.
33. 2+ channel in the initiation and maintenance of ventricular fibrillation. Circ Res. 1990;67:1115-1123.
34. 2+ channel antagonist, flunarizine, protects against ventricular fibrillation. Eur J Pharmacol. 1992; 212:231-235.
35. 2+ channel antagonist, protects against ventricular fibrillation. Eur J Pharmacol. 1992; 229:179-187.
36. Lappi MD, Billman GE. Effect of ryanodine on ventricular fibrillation induced by myocardial ischemia. Cardiovasc Res. 1993;27:2152-2159.
37. Ferrier GR. Digitalis arrhythmias: role of oscillatory afterpotentials. Prog Cardiovasc Dis. 1977;19:459-474.
38. Avendano CE, Billman GE. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs. Eur J Pharmacol. 1994;255:99-109.
39. 2+ channels. Ann N Y Acad Sci. 1989;560:373-386.
40. 2-Adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res. 1995;76:40-52.
41. 2-adrenergic receptor. Science. 1994;264:582-586.